Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 11:08:49 UTC |
---|
Update Date | 2021-09-26 23:05:56 UTC |
---|
HMDB ID | HMDB0252982 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide |
---|
Description | N-(3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}-2-({4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl}amino)propyl)propanimidic acid belongs to the class of organic compounds known as phenyl-1,3-oxazoles. These are aromatic heterocyclic compounds containing a 1,3-oxazole substituted at one or more positions by a phenyl group. Based on a literature review very few articles have been published on N-(3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}-2-({4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl}amino)propyl)propanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(2s)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C=C1)NC(C)=CC(=O)C1=CC=C(C=C1)C(F)(F)F InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43) |
---|
Synonyms | Value | Source |
---|
N-(3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}-2-({4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl}amino)propyl)propanimidate | Generator |
|
---|
Chemical Formula | C35H36F3N3O4 |
---|
Average Molecular Weight | 619.685 |
---|
Monoisotopic Molecular Weight | 619.26579114 |
---|
IUPAC Name | N-(3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}-2-({4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl}amino)propyl)propanamide |
---|
Traditional Name | N-(3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}-2-({4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl}amino)propyl)propanamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C=C1)NC(C)=CC(=O)C1=CC=C(C=C1)C(F)(F)F |
---|
InChI Identifier | InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43) |
---|
InChI Key | TYEFSRMOUXWTDN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenyl-1,3-oxazoles. These are aromatic heterocyclic compounds containing a 1,3-oxazole substituted at one or more positions by a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Oxazoles |
---|
Direct Parent | Phenyl-1,3-oxazoles |
---|
Alternative Parents | |
---|
Substituents | - Phenyl-1,3-oxazole
- Amphetamine or derivatives
- Trifluoromethylbenzene
- 2,4,5-trisubstituted 1,3-oxazole
- Phenoxy compound
- Benzoyl
- Phenol ether
- Aryl ketone
- Alkyl aryl ether
- Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- Vinylogous amide
- Alpha,beta-unsaturated ketone
- Heteroaromatic compound
- Acryloyl-group
- Enone
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Ketone
- Azacycle
- Oxacycle
- Secondary amine
- Carboxylic acid derivative
- Secondary aliphatic amine
- Enamine
- Ether
- Organic oxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Aldehyde
- Alkyl fluoride
- Alkyl halide
- Organooxygen compound
- Amine
- Organonitrogen compound
- Organohalogen compound
- Organofluoride
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 239.782 | 30932474 | DeepCCS | [M-H]- | 237.478 | 30932474 | DeepCCS | [M-2H]- | 270.717 | 30932474 | DeepCCS | [M+Na]+ | 245.522 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 4687.2 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 4245.7 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 5479.2 | Standard polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 4752.8 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 4294.9 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C | 5430.9 | Standard polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C)[Si](C)(C)C | 4685.7 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C)[Si](C)(C)C | 4284.6 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C)[Si](C)(C)C | 5182.4 | Standard polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 4888.5 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 4409.1 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)NC(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 5466.1 | Standard polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 4947.8 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 4433.7 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,1TBDMS,isomer #2 | CCC(=O)NCC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C | 5405.1 | Standard polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5031.2 | Semi standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4561.6 | Standard non polar | 33892256 | N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide,2TBDMS,isomer #1 | CCC(=O)N(CC(CC1=CC=C(OCCC2=C(C)OC(C3=CC=CC=C3)=N2)C=C1)N(C(C)=CC(=O)C1=CC=C(C(F)(F)F)C=C1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5201.5 | Standard polar | 33892256 |
|
---|